Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis

Ronald A. Lubet, Eva Szabo, Kenneth K. Iwata, Stanley C. Gill, Chris Tucker, Ann Bode, Vernon E. Steele, M. Margaret Juliana, Holly L. Nicastro, Clinton J. Grubbs

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science